compound glp 1 news New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our GLP-1 Medications for Seniors |
Description
Briefly, digestion occurred at 37C and was stopped with application of ice-cold RMPI (Thermo Fisher Scientific, 11875119, 2 mM L-glutamine, 0.25% BSA)
However, individuals with kidney disease may need to restrict protein, making high-protein supplements problematic
How does provider support help patients achieve better outcomes with GLP-1s
It's an investigational drug currently in Phase 3 clinical trials
M., Castle, I
The strategic question becomes: whats left to market when belief is optional
